Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 549, Issue 1-2, Pages 58-66Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2018.07.054
Keywords
Dry powder inhalers; Biologics; Formulation drug loading; Devices
Categories
Funding
- Amgen Inc.
Ask authors/readers for more resources
The number of biologics in the therapeutic development pipeline is increasing including those delivered though inhalation (Morales, 2017; Fathe, 2016). Biologics comprise a broad variety of complex macromolecules with unique physicochemical characteristics. These distinctive characteristics control their pharmacological mechanisms of action, stability, and ultimately affect their processing, formulation, and delivery requirements. This review systematically covers crucial aspects of biologic powders formulations and dry powder inhalers which need to be taken into consideration to establish the drug loading and the payload to be delivered to reach the desired clinical dose.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available